
Atara Biotherapeutics Inc
NASDAQ:ATRA

Intrinsic Value
The intrinsic value of one
ATRA
stock under the Base Case scenario is
19.48
USD.
Compared to the current market price of 8.42 USD,
Atara Biotherapeutics Inc
is
Undervalued by 57%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Atara Biotherapeutics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Atara Biotherapeutics Inc
Balance Sheet Decomposition
Atara Biotherapeutics Inc
Current Assets | 27.2m |
Cash & Short-Term Investments | 13.8m |
Receivables | 8.9m |
Other Current Assets | 4.5m |
Non-Current Assets | 34.9m |
PP&E | 32m |
Other Non-Current Assets | 2.8m |
Free Cash Flow Analysis
Atara Biotherapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Atara Biotherapeutics Inc
Revenue
|
199.7m
USD
|
Cost of Revenue
|
-39.5m
USD
|
Gross Profit
|
160.3m
USD
|
Operating Expenses
|
-159.4m
USD
|
Operating Income
|
880k
USD
|
Other Expenses
|
-16.5m
USD
|
Net Income
|
-15.6m
USD
|
ATRA Profitability Score
Profitability Due Diligence
Atara Biotherapeutics Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Score
Atara Biotherapeutics Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
ATRA Solvency Score
Solvency Due Diligence
Atara Biotherapeutics Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.

Score
Atara Biotherapeutics Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ATRA Price Targets Summary
Atara Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for
ATRA
is 15.64 USD
with a low forecast of 11.11 USD and a high forecast of 18.9 USD.
Dividends
Current shareholder yield for ATRA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ATRA
stock under the Base Case scenario is
19.48
USD.
Compared to the current market price of 8.42 USD,
Atara Biotherapeutics Inc
is
Undervalued by 57%.